ubenimex (DFP-14323) / Delta-Fly Pharma 
Welcome,         Profile    Billing    Logout  
  Diseases    Trials    Trials    News 
2 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
ubenimex (DFP-14323) / Delta-Fly Pharma
ChiCTR2200060145: Ubenimex capsules (Bestatin) and chemotherapy for the patients with metastatic breast cancer (MBC): A real-world study

Not yet recruiting
4
1304
 
NA
Zhejiang Cancer Hospital; Zhejiang Cancer Hospital, Zhejiang Apeloa Kangyu Pharmaceutical Co., Ltd.
breast cancer
 
 
UBE-Q, jRCT2031210707: Phase II Trial of Ubenimex Combined with Pembrolizumab + nab-Paclitaxel + Carboplatin for Untreated Patients with Advanced Squamous Non-Small Cell Lung Cancer:

Recruiting
2
54
Japan
Keytruda (pembrolizumab) - Merck (MSD), albumin-bound paclitaxel - Generic mfg., carboplatin - Generic mfg., ubenimex (DFP-14323) - Delta-Fly Pharma
Nippon Medical School Hospital, Nippon Kayaku Co., Ltd.
Squamous non-small cell lung cancer(SqCLC)
 
 

Download Options